Obesity; Drug Clinical Trial
Official title:
Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight Control :A Randomized, Open, Controlled and Single-site Clinical Trail
This is a randomized, open, controlled and single-site clinical trail to investigate the effect and safety of Benaglutide or Metformin in patients with simple obesity who have inadequate weight control.
This is a randomized, open, controlled and single-site clinical trail to investigate the
effect and safety of Benaglutide or Metformin in patients with simple obesity who have
inadequate weight control.
Screening will be made to select eligible participants before intervention. Patients were
randomly assigned to one of two groups(metformin or benaglutide) for therapies for 12 weeks
including a two-week dose adjustment period and a 10-week dose stabilization period.
Lifestyle interventions will be maintained during the treatment period. Subjects are followed
up every 4 weeks for examinations.At the end of the study, data will be collected and
analyzed.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05162001 -
Body Weight Response With Disulfiram in Humans
|
Early Phase 1 | |
| Completed |
NCT03141476 -
Adequacy of Perioperative Cefuroxime Dosage According to the BMI
|
Phase 4 | |
| Recruiting |
NCT05176626 -
Long-term Effectiveness of the Antiobesity Medication Phentermine
|
Phase 4 | |
| Not yet recruiting |
NCT06431308 -
Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events
|
N/A | |
| Completed |
NCT04730375 -
Evaluation of the Effect of Different Doses Dexmedetomidine Infusion on Lung Mechanics and Oxygenation in Obese Patients
|
Phase 2 | |
| Recruiting |
NCT05087342 -
Latino Semaglutide Study
|
Phase 3 | |
| Recruiting |
NCT06390501 -
The Effect of Weekly Semaglutide Treatment on Energy Expenditure
|
N/A |